Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money
Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.
Select the one that best describes you

PPH
VanEck Vectors Pharmaceutical ETF

Price: $64.83
Change: $0.49 (-0.01%)
Category: Health & Biotech Equities
Last Updated:

Vitals

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $53.86
  • 52 Week Hi $67.00
  • AUM $178.9 M
  • Shares 2.7 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume 61,995
  • 3 Month Avg. Volume 53,268

Alternative ETFs in the Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $1.8 B 163,225 -0.32%
Largest (AUM) XLV 0.13% $20.4 B 7 M -0.18%
Most Liquid (Volume) XLV 0.13% $20.4 B 7 M -0.18%
Top YTD Performer HTEC 0.68% $8.9 M 5,505 2.39%

Top 10 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

Number of Holdings
26
Low: MJJ (23)
High: VHT (386)
Rank:
38 of 40
% Assets in Top 10
49.49%
Low: HTEC (15.62%)
High: MJJ (77.61%)
Rank:
30 of 40
% Assets in Top 15
72.23%
Low: BBC (22.27%)
High: MJJ (92.90%)
Rank:
9 of 40
% Assets in Top 50
100.00%
Low: BBC (60.62%)
High: XHS (100.00%)
Rank:
14 of 40
 
View Summary Analysis
 
26
Number of Holdings
49.49%
% Assets in Top 10
72.23%
% Assets in Top 15
100.00%
% Assets in Top 50
 
View Detailed Analysis
 

26
Number of Holdings
49.49%
% Assets in Top 10
72.23%
% Assets in Top 15
100.00%
% Assets in Top 50
 
View Detailed Analysis
 
Number of Holdings
26
Rank
38 of 40
Low
MJJ (23)
High
VHT (386)
% Assets in Top 10
49.49%
Rank
30 of 40
Low
HTEC (15.62%)
High
MJJ (77.61%)
% Assets in Top 15
72.23%
Rank
9 of 40
Low
BBC (22.27%)
High
MJJ (92.90%)
% Assets in Top 50
100.00%
Rank
14 of 40
Low
BBC (60.62%)
High
XHS (100.00%)

 
View Summary Analysis
 

Sector Breakdown

Asset Percentage
Common equity 100.0%
Sector Percentage
Healthcare 92.74%
Other 7.26%
Market Cap Percentage
Large cap 71.58%
Mid cap 26.6%
Small cap 1.82%
Region Percentage
North America 59.85%
Europe 31.49%
Middle East 4.37%
Asia-Pacific 4.28%
Region Percentage
United States 55.96%
Developed Markets (ex-US) 44.04%
Country Percentage
United States 55.96%
United Kingdom 13.62%
Denmark 5.18%
Switzerland 4.86%
France 4.79%
Israel 4.37%
Japan 4.28%
Canada 3.89%
Ireland 3.05%
 
View Less Charts
 
Asset Percentage
Common equity 100.0%
 
View More Charts
 

PPH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

P/E Ratio
26.16
Low: GNOM (-21.29)
High: PTH (495.74)
Rank:
22 of 34
P/E Ratio
26.16
Rank
22 of 34
Low
GNOM (-21.29)
High
PTH (495.74)

PPH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Dividend
$0.17
Dividend Date
2019-12-30
Annual Dividend Rate
$1.14

$0.17
Dividend
2019-12-30
Dividend Date
$1.14
Annual Dividend Rate
Annual Dividend Yield
1.74%
Low: IDNA (0.01%)
High: ARKG (3.13%)
Rank:
5 of 29
Annual Dividend Yield
1.74%
Rank
5 of 29
Low
IDNA (0.01%)
High
ARKG (3.13%)

PPH Fund Flows

This section compares the fund flows of this ETF to peers in the same ETFdb.com Category.

Realtime Rating

The adjacent table gives investors an individual Realtime Rating for PPH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Sign Up for Pro to Unlock Data Sign Up
Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A- n/a
Expenses A- n/a
Performance
Volatility
Dividend
Concentration

A+ Overall Rated ETF:

Analyst Report

This ETF is one of several options for achieving exposure to the pharma industry, a corner of the health care market that is capable of delivering big returns but that also comes with some unique risk factors. Given this investment objective, PPH is probably more useful for those looking to achieve tactical exposure to this specific corner of the market; the appeal to buy-and-holders will be limited since many of the components are included in more broad-based funds.

A couple aspects of PPH are noteworthy. First, though PPH is now structured as a true ETF, it used to be one of the HOLDRS products offered by Merrill Lynch. Some of the concentration that was characteristic of those products remains in PPH; the portfolio is relatively shallow and concentration in the top allocations is significant. Further, PPH includes only U.S. stocks, meaning that some of the biggest players in the pharmaceutical industry are excluded from the underlying portfolio.

PPH is a decent option for pharma exposure, but there are probably some better ETFs out there for tapping into this segment of the market. IHE offers better depth of holdings, while DRGS may be appealing to those looking to achieve truly global exposure.

PPH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Expenses Ratio Analysis

ETF Average
0.544%
ETF Wtd. Average
0.19%
Category Average
0.47%
ESG Themes and Scores
6.11/10
ESG Score
67.47%
Global Percentile
84.43%
Peer Percentile
Environmental
Social
Governance
  • Environmental Scores
    • Revenue Exposure to Environmental Impact (%)
      Higher is better, no ESG score impact
    • Severe Environment Controversies (%)
      Lower improves ESG score
    • Sustainable Impact Solutions (%)
      12.95%
      Higher is better, no ESG score impact
    Carbon Intensity
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      27.09
      Higher is worse, no ESG score impact
    Fossil Fuel Reserves
    • Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    • High Impact Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    Water Stress
    • Water Stress High Risk Business Segment (%)
      Lower improves ESG score
    • Water Stress High Risk Geography (%)
      Lower improves ESG score
    • Water Stress Exposure Moderate (%)
      Lower improves ESG score
    • Water Stress Exposure High (%)
      Lower improves ESG score
    • Water Stress Exposure Low (%)
      Higher improves ESG score
    Energy Efficiency
    • Revenue Exposure to Energy Efficiency (%)
      Higher is better, no ESG score impact
    Alternative Energy
    • Revenue Exposure to Alternative Energy (%)
      Higher is better, no ESG score impact
    Green Building
    • Revenue Exposure to Green Building (%)
      Higher is better, no ESG score impact
    Pollution Prevention
    • Revenue Exposure to Pollution Prevention (%)
      Higher is better, no ESG score impact
    Water Sustainability
    • Revenue Exposure to Water Sustainability (%)
      Higher is better, no ESG score impact
  • Social Scores
    • Revenue Exposure to Social Impact (%)
      Higher is better, no ESG score impact
    • Sustainable Impact Solutions (%)
      12.95%
      Higher is better, no ESG score impact
    • SRI Exclusion Criteria (%)
      0.0%
      Higher is worse, no ESG score impact
    Affordable Real Estate
    • Revenue Exposure to Affordable Real Estate (%)
      Higher is better, no ESG score impact
    Education
    • Revenue Exposure to Education (%)
      Higher is better, no ESG score impact
    Major Disease Treatment
    • Revenue Exposure to Major Disease Treatment (%)
      Higher is better, no ESG score impact
    Healthy Nutrition
    • Revenue Exposure to Nutrition (%)
      Higher is better, no ESG score impact
    Global Sanitation
    • Revenue Exposure to Sanitation (%)
      Higher is better, no ESG score impact
    SME Finance
    • Revenue Exposure to SME Finance (%)
      Higher is better, no ESG score impact
    Human Rights Violations
    • Human Rights Norms Violation (%)
      Higher is worse, no ESG score impact
    • Human Rights Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Human Rights Controversies (%)
      Lower improves ESG score
    Labor Rights Violations
    • Labor Norms Violation (%)
      Higher is worse, no ESG score impact
    • Labor Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Labor Controversies (%)
      Lower improves ESG score
    Customer Controversies
    • Severe Customer Controversies (%)
      Lower improves ESG score
    UN Principles Violations
    • Global Compact Compliance Violation (%)
      Higher is worse, no ESG score impact
    • Global Compact Compliance Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    Catholic Values
    • Catholic Values Fail (%)
      Higher is worse, no ESG score impact
    Sharia Compliant Investing
    • Islamic Non-Compliant (%)
      Higher is worse, no ESG score impact
    Adult Entertainment
    • Adult Entertainment Involvement (%)
      Higher is worse, no ESG score impact
    Alcohol
    • Alcohol Involvement (%)
      Higher is worse, no ESG score impact
    Gambling
    • Gambling Involvement (%)
      Higher is worse, no ESG score impact
    Nuclear Power
    • Nuclear Power Involvement (%)
      Higher is worse, no ESG score impact
    Tobacco
    • Tobacco Involvement (%)
      Higher is worse, no ESG score impact
    Weapons Involvement
    • Weapons Involvement (%)
      Higher is worse, no ESG score impact
    • Controversies Weapons Involvement (%)
      Higher is worse, no ESG score impact
    Firearms
    • Civilian Firearms Involvement (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Retailer (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Producer (%)
      Higher is worse, no ESG score impact
    Predatory Lending
    • Direct Predatory Lending Involvement (%)
      Higher is worse, no ESG score impact
    GMO Involvement
    • Genetic Engineering Involvement (%)
      Higher is worse, no ESG score impact
  • Responsible Governance Score
    • Severe Governance Controversies (%)
      Lower improves ESG score
    Board Flag
    • Board Flag (%)
      Lower improves ESG score
    Board Independence
    • Lack of Independent Board Majority (%)
      Lower improves ESG score
    • Board Independence (0-25%) (%)
      Lower improves ESG score
    • Board Independence (25-50%) (%)
      Lower improves ESG score
    • Board Independence (50-75%) (%)
      Higher improves ESG score
    • Board Independence (75-100%) (%)
      Higher improves ESG score
    Board Diversity
    • No Female Directors (%)
      Lower improves ESG score
    • Three OR More Female Directors (%)
      Higher improves ESG score
    • Females Represent 30% of Directors (%)
      Higher improves ESG score
    Entrenched Board
    • Entrenched Board (%)
      Lower improves ESG score
    Overboarding
    • Overboarding (%)
      Lower improves ESG score
    Shareholder Rights
    • Negative Director Votes (%)
      Lower improves ESG score
    • Ownership AND Control Flag (%)
      Lower improves ESG score
    • One Share One Vote (%)
      Lower improves ESG score
    • No Annual Director Elections (%)
      Lower improves ESG score
    • Does Not Use Majority Voting (%)
      Lower improves ESG score
    • Significant Votes Against Pay Practices (%)
      Lower improves ESG score
    Fund Ownership
    • Controlling Shareholder (%)
      Lower improves ESG score
    • Controlling Shareholder Concerns (%)
      Lower improves ESG score
    • Cross Shareholdings (%)
      Lower improves ESG score
    Poison Pill
    • Poison Pill (%)
      Lower improves ESG score
    Executive Compensation
    • Pay Flag (%)
      Lower improves ESG score
    • No Pay Performance Link (%)
      Lower improves ESG score
    • Lack of Internal Pay Equity (%)
      Lower improves ESG score
    • Executive Pay Non-Disclosure (%)
      Lower improves ESG score
    Accounting Flags
    • Accounting Flag (%)
      Lower improves ESG score

PPH Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

1 Week Return
-2.76%
Low: GNOM (-8.08%)
High: IHI (-1.03%)
Rank:
12 of 40
4 Week Return
1.56%
Low: SBIO (-6.15%)
High: MJJ (3.58%)
Rank:
8 of 39
13 Week Return
10.68%
Low: KMED (2.36%)
High: BBC (38.68%)
Rank:
17 of 39
26 Week Return
12.40%
Low: ARKG (0.24%)
High: BBC (30.75%)
Rank:
7 of 39
Year to Date Return
1.01%
Low: SBIO (-6.46%)
High: HTEC (2.39%)
Rank:
8 of 40
1 Year Return
15.19%
Low: PJP (-1.18%)
High: BBC (46.69%)
Rank:
20 of 35
3 Year Return
34.20%
Low: PJP (20.20%)
High: ARKG (98.21%)
Rank:
24 of 31
5 Year Return
7.12%
Low: XPH (-17.37%)
High: IHI (140.37%)
Rank:
21 of 26
 
View Summary Analysis
 
-2.76%
1 Week Return
1.56%
4 Week Return
10.68%
13 Week Return
12.40%
26 Week Return
1.01%
Year to Date Return
15.19%
1 Year Return
34.20%
3 Year Return
7.12%
5 Year Return
 
View Detailed Analysis
 

-2.76%
1 Week Return
1.56%
4 Week Return
10.68%
13 Week Return
12.40%
26 Week Return
1.01%
Year to Date Return
15.19%
1 Year Return
34.20%
3 Year Return
7.12%
5 Year Return
 
View Detailed Analysis
 
1 Week Return
-2.76%
Rank
12 of 40
Low
GNOM (-8.08%)
High
IHI (-1.03%)
4 Week Return
1.56%
Rank
8 of 39
Low
SBIO (-6.15%)
High
MJJ (3.58%)
13 Week Return
10.68%
Rank
17 of 39
Low
KMED (2.36%)
High
BBC (38.68%)
26 Week Return
12.40%
Rank
7 of 39
Low
ARKG (0.24%)
High
BBC (30.75%)
Year to Date Return
1.01%
Rank
8 of 40
Low
SBIO (-6.46%)
High
HTEC (2.39%)
1 Year Return
15.19%
Rank
20 of 35
Low
PJP (-1.18%)
High
BBC (46.69%)
3 Year Return
34.20%
Rank
24 of 31
Low
PJP (20.20%)
High
ARKG (98.21%)
5 Year Return
7.12%
Rank
21 of 26
Low
XPH (-17.37%)
High
IHI (140.37%)

 
View Summary Analysis
 

PPH Charts

PPH Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

Technicals

  • 20 Day MA $65.00
  • 60 Day MA $62.77
  • MACD 15 Period -0.46
  • MACD 100 Period 4.46
  • Williams % Range 10 Day 72.58
  • Williams % Range 20 Day 58.49
  • RSI 10 Day 45
  • RSI 20 Day 55
  • RSI 30 Day 58
  • Ultimate Oscillator 48

Bollinger Brands

  • Lower Bollinger (10 Day) $64.15
  • Upper Bollinger (10 Day) $67.77
  • Lower Bollinger (20 Day) $62.55
  • Upper Bollinger (20 Day) $67.37
  • Lower Bollinger (30 Day) $62.43
  • Upper Bollinger (30 Day) $66.86

Support & Resistance

  • Support Level 1 $64.25
  • Support Level 2 $63.66
  • Resistance Level 1 $65.18
  • Resistance Level 2 $65.52

Stochastic

  • Stochastic Oscillator %D (1 Day) 61.68
  • Stochastic Oscillator %D (5 Day) 43.60
  • Stochastic Oscillator %K (1 Day) 57.46
  • Stochastic Oscillator %K (5 Day) 61.61

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the fact sheet PDF

Brought to You by ETF Flows

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2020 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.
Help & Info
Tools
More Tools
Explore ETFs
Legal